Cosmo Bio Company,Limited 3386.T Stock
Cosmo Bio Company,Limited Price Chart
Cosmo Bio Company,Limited 3386.T Financial and Trading Overview
Cosmo Bio Company,Limited stock price | 1003 JPY |
Previous Close | 946 JPY |
Open | 944 JPY |
Bid | 941 JPY x 0 |
Ask | 945 JPY x 0 |
Day's Range | 941 - 948 JPY |
52 Week Range | 937 - 1117 JPY |
Volume | 7.4K JPY |
Avg. Volume | 6.31K JPY |
Market Cap | 5.47B JPY |
Beta (5Y Monthly) | 0.627586 |
PE Ratio (TTM) | 13.184811 |
EPS (TTM) | 75.93 JPY |
Forward Dividend & Yield | 30 (3.18%) |
Ex-Dividend Date | June 29, 2023 |
1y Target Est | N/A |
3386.T Valuation Measures
Enterprise Value | 3.06B JPY |
Trailing P/E | 13.184811 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.58606535 |
Price/Book (mrq) | 0.66311735 |
Enterprise Value/Revenue | 0.328 |
Enterprise Value/EBITDA | 3.959 |
Trading Information
Cosmo Bio Company,Limited Stock Price History
Beta (5Y Monthly) | 0.627586 |
52-Week Change | -7.52% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1117 JPY |
52 Week Low | 937 JPY |
50-Day Moving Average | 946.22 JPY |
200-Day Moving Average | 990.16 JPY |
3386.T Share Statistics
Avg. Volume (3 month) | 6.31K JPY |
Avg. Daily Volume (10-Days) | 5.5K JPY |
Shares Outstanding | 5.81M |
Float | 2.14M |
Short Ratio | N/A |
% Held by Insiders | 20.00% |
% Held by Institutions | 19.04% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 36 |
Trailing Annual Dividend Yield | 3.80% |
5 Year Average Dividend Yield | 210.00% |
Payout Ratio | 0.50450003 |
Last Split Factor | 100:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.44% |
Operating Margin (ttm) | 6.83% |
Gross Margin | 35.55% |
EBITDA Margin | 8.27% |
Management Effectiveness
Return on Assets (ttm) | 3.75% |
Return on Equity (ttm) | 5.15% |
Income Statement
Revenue (ttm) | 9.33B JPY |
Revenue Per Share (ttm) | 1606.36 JPY |
Quarterly Revenue Growth (yoy) | -7.19% |
Gross Profit (ttm) | 3.44B JPY |
EBITDA | 772.75M JPY |
Net Income Avi to Common (ttm) | 415M JPY |
Diluted EPS (ttm) | 71.37 |
Quarterly Earnings Growth (yoy) | -27.90% |
Balance Sheet
Total Cash (mrq) | 3.03B JPY |
Total Cash Per Share (mrq) | 520.56 JPY |
Total Debt (mrq) | 20M JPY |
Total Debt/Equity (mrq) | 0.23 JPY |
Current Ratio (mrq) | 6.283 |
Book Value Per Share (mrq) | 1419.055 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Cosmo Bio Company,Limited
Country | Japan |
State | N/A |
City | Tokyo |
Address | Toyo-Ekimae Building |
ZIP | 135-0016 |
Phone | 81 3 5632 9600 |
Website | https://www.cosmobio.co.jp |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 146 |
Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as offers detection reagents, cell and tissue culture systems, gene analysis systems, and others. It also provides research instruments comprising electrophoresis apparatuses, cell culture labware, gene manipulation systems, data analysis software, and others; drug discovery and custom research services; and clinical diagnostics. In addition, the company develops and manufactures cell/cell culture products, including adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem, and feeder cells, as well as tumor cell lines, coating reagents, macrophage-related products, etc.; and assay kit related products that comprise various measurement kits, staining kits, detection/purification kits, etc. Further, it offers biotechnology research equipment, which include constant-temperature transport containers, aluminum block mat heat insulation devices, dew condensation prevention glass plates, etc.; and consigned, custom peptide synthesis, and antibody production services. The company serves laboratories, research institutes, and life-science education and testing organizations. It sells its products through outlets in Japan, as well as a network of sales agents internationally. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Tokyo, Japan.
Q&A For Cosmo Bio Company,Limited Stock
What is a current 3386.T stock price?
Cosmo Bio Company,Limited 3386.T stock price today per share is 1003 JPY.
How to purchase Cosmo Bio Company,Limited stock?
You can buy 3386.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cosmo Bio Company,Limited?
The stock symbol or ticker of Cosmo Bio Company,Limited is 3386.T.
Which industry does the Cosmo Bio Company,Limited company belong to?
The Cosmo Bio Company,Limited industry is Diagnostics & Research.
How many shares does Cosmo Bio Company,Limited have in circulation?
The max supply of Cosmo Bio Company,Limited shares is 5.84M.
What is Cosmo Bio Company,Limited Price to Earnings Ratio (PE Ratio)?
Cosmo Bio Company,Limited PE Ratio is 13.20953500 now.
What was Cosmo Bio Company,Limited earnings per share over the trailing 12 months (TTM)?
Cosmo Bio Company,Limited EPS is 75.93 JPY over the trailing 12 months.
Which sector does the Cosmo Bio Company,Limited company belong to?
The Cosmo Bio Company,Limited sector is Healthcare.